フローサイトメトリー市場の規模、シェア、動向分析レポート：製品別（装置、ソフトウェア）、技術別（ビーズベース、セルベース）、用途別（産業、臨床）、最終用途別、セグメント別予測、2022年～2030年

フローサイトメトリー市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、フローサイトメトリーの世界市場規模は、予測期間中にCAGR 7.07%を記録し、2030年までに92億8000万米ドルに達すると予測されています。この技術の進歩により、ポイントオブケア（PoC）検査用のマイクロ流体フローサイトメトリーの開発など、新しく改良された分析ツールが導入されつつあります。さらに、がん、免疫不全疾患、感染症などの有病率の上昇が、業界を牽引しています。さらに、バイオ医薬品、ライフサイエンス、バイオテクノロジーの研究活動における研究開発投資の増加が、フローサイトメトリー装置の高い需要につながっています。近年では、PoC検査用の携帯型マイクロ流体フローサイトメトリー装置の開発が重要な焦点となっています。

マイクロ流体解析とフローサイトメトリーの組み合わせは、生体サンプルの複数の特性を測定するための有用なツールとなります。例えば、複数のマイクロ流体や小型化された検出器が容易に入手できるようになったことで、光流体サイトメーター、イメージングサイトメーター、インピーダンスサイトメーターなど、マイクロチップを用いたサイトメーターの開発が可能になっています。マイクロ流体フローサイトメトリーデバイスの開発は、費用対効果が高く、携帯可能でコンパクトであるため、有益です。さらに、蛍光色素の改良と学術研究環境におけるベンチトップサイトメーターの有用性の向上が、業界を牽引すると予想されます。

マルチカラーフローサイトメトリーの開発は、新薬開発活動における同技術の採用を加速しています。例えば、2020年1月、Beckman Coulter Life Sciences社から13色の臨床用フローサイトメトリーシステムであるDxFLEX、CE-IVDが欧州で発売されました。同様に、複数のパラメーターを同時に評価することで簡単に細胞分析ができるため、受託研究目的でこのような装置を幅広く利用することができます。COVID-19の大流行も、この領域での新製品の発売が示すように、技術の革新に拍車をかけています。例えば、2021年7月、メトロポリスヘルスケア株式会社は、COVID-19入院患者のリスク状態を検出するための簡単な血液検査であるCoviRisk-TBNKを発売しました。

患者のICU設備や人工呼吸の必要性を分析し、医療資源のストレス軽減を支援します。この検査はフローサイトメトリーベースのリンパ球サブセットアッセイで、体外診断用医薬品として承認されています。さらに、フローサイトメトリーは、免疫細胞のリストアップと特性解析における重要なツールであり、根本的な遺伝的欠陥の認識と検証にも有用です。この技術は、幹細胞移植後の患者の免疫反応を観察・監視するためにも使用されており、したがって、臓器移植は業界の成長を後押しする重要な役割を担っているのです。WHOによると、全世界で毎年約5万件の幹細胞移植が行われており、この数は近い将来に増加すると予想され、この技術の応用範囲を広げています。

一方、装置は非常に高価であるため、いくつかの新興諸国では、技術的に高度なフローサイトメトリー装置を購入することができない場合があります。これらの機器は10万米ドル以上することもあり、中小規模の病院や臨床検査室にとっては予算的に大きな制約となります。しかし、ソニーのようなメーカーが、多くのプロセスを自動化するソフトウェアを使用した新しい装置を発売しようとしています。このような開発は、技術の使い勝手を向上させるだけでなく、近い将来、装置の平均コスト（10万米ドル以下）を引き下げるのに役立つと思われます。

フローサイトメトリー市場レポートハイライト

2021年には、技術の進歩や慢性疾患の増加により、装置製品分野が最大のシェアを占めました。

セルベースフローサイトメトリー技術は、早期診断の高い需要と、セルベースアッセイの関連メリットに関する認知度の上昇により、2021年に業界を支配した

アプリケーション別では、インフルエンザ、HIV、COVID-19などの感染症に関する研究開発活動の増加により、臨床セグメントが2021年に最大の売上シェアを占めました。

学術機関のエンドユーザー部門は、学術機関や研究所による研究開発活動の増加により、2021年に市場をリードした

北米は、科学的に高度なフローサイトメトリーソリューションの高い導入率、高いヘルスケア支出、確立されたヘルスケアインフラにより、2021年に市場をリードする地域となりました。

2022年から2030年にかけて、中国やインドなどの新興国における製薬およびバイオテクノロジー産業の成長により、アジア太平洋地域が最も速いCAGRを記録すると予想されています。

目次

第1章 調査手法と範囲

• 調査手法
• 調査の仮定
• 情報調達
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析（モデル1）
    • アプローチ1：コモディティフローアプローチ
  • 出来高価格分析（モデル2）
    • アプローチ2：出来高価格分析
• 二次情報のリスト
• 目的
  • フローサイトメトリー市場の市場予測

第2章 エグゼクティブサマリー

• 市場のスナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 フローサイトメトリー市場の変数、動向、および範囲

• 市場系列の見通し
  • 親市場の見通し
  • 関連/補助的な市場の見通し
• 浸透と成長の見通しのマッピング
  • 製品ごとに優先される主要な機会
  • テクノロジごとに優先される主要な機会
  • アプリケーション別に優先される主要な機会
  • 最終用途別に優先される主要な機会
• 市場力学
  • 市場促進要因分析
    • 慢性疾患および感染症の蔓延
    • バイオテクノロジー、臨床、ライフサイエンス調査への多額の研究開発投資
    • フローサイトメトリー機器および試薬の技術的進歩
    • ポイントオブケア診断の需要の増加
  • 市場抑制要因分析
    • 機器の高コスト
  • 市場の課題
    • 低いセルスループットレート
• フローサイトメトリー：市場分析ツール
  • 業界分析- ポーターズ
  • フローサイトメトリー-SWOT分析、要因別（政治と法律、経済と技術）
• 規制と償還のシナリオ
• 価格分析
• 取引データ
  • フローサイトメーターの国別データのインポート/エクスポート
• COVID-19影響分析

第4章 製品ビジネス分析

• フローサイトメトリー市場：製品変動分析、2021 &2030
• 楽器
  • 細胞分析装置
  • セルソーター
• 試薬と消耗品
• ソフトウェア
• 付属品
• サービス

第5章 テクノロジービジネス分析

• フローサイトメトリー市場：技術変動分析、2021 &2030
• セルベース
• ビーズベース

第6章 アプリケーションビジネス分析

• フローサイトメトリー市場：アプリケーションの変動分析、2021 &2030
• 研究
  • 医薬品
    • 創薬
    • インビトロ毒性
    • 幹細胞
  • アポトーシス
  • セルソーティング
  • 細胞周期分析
  • 免疫学
  • 細胞生存率
• 工業
• 臨床
  • がん
  • 臓器移植
  • 免疫不全
  • 血液学

第7章 最終用途ビジネス分析

• フローサイトメトリー市場：最終用途変動分析、2021 &2030
• 営利団体
  • バイオテクノロジー企業
  • 製薬会社
  • クロス
• 病院
• 学術機関
• 臨床検査ラボ

第8章 地域ビジネス分析

• フローサイトメトリー市場：地域変動分析
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • ロシア
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • シンガポール
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東とアフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第9章 フローサイトメトリー市場の競合情勢

• 主要な市場参入企業別最近の動向と影響分析
• 会社の分類
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
• 公開会社
  • 会社の市況分析
  • 世界主要企業の市場シェア分析、2021年
• 非公開会社
  • 主要な新興企業のリスト
  • 会社の市況分析
• Regional Network Map
• 企業プロファイル
  • DANAHER CORPORATION
    • 会社概要
    • ベックマン・コールター社
    • 会社概要
    • シティバ
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BECTON, DICKINSON AND COMPANY（BD）
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • SYSMEX CORPORATION
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • AGILENT TECHNOLOGIES, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • APOGEE FLOW SYSTEMS LTD.
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BIO-RAD LABORATORIES, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • THERMO FISHER SCIENTIFIC, INC.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • STRATEDIGM, INC.
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • DIASORIN SPA
    • 会社概要
    • 株式会社ルミネックス
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • MILTENYI BIOTEC
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • SONY BIOTECHNOLOGY, INC.
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of secondary sources
• Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
• Table 3 CPT codes for flow cytometry reimbursement
• Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
• Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 22 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 23 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 24 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 25 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 26 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 27 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 28 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 29 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 30 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 31 U.K. flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 32 U.K. flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 33 U.K. flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 34 U.K. flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 35 France flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 36 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 37 France flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 38 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 39 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 40 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 41 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 42 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 43 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 44 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 45 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 46 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 47 Russia flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 48 Russia flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 49 Russia flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 50 Russia flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 51 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 52 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 53 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 54 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 55 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 56 China flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 57 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 58 China flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 59 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 60 India flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 61 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 62 India flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 63 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 64 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 65 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 66 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 67 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 68 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 69 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 70 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 71 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 72 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 73 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 74 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 75 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 76 Singapore flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 77 Singapore flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 78 Singapore flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 79 Singapore flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 80 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 81 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 82 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 83 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 84 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 85 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 86 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 87 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 88 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 89 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 90 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 91 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 92 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 93 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 94 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 95 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 96 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 97 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
• Table 98 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 99 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 100 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 101 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 102 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 103 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 104 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 105 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
• Table 110 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
• Table 111 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
• Table 112 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
• Table 113 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Commodity flow analysis
• Fig. 10 Volume price analysis
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook (2021)
• Fig. 15 Penetration & growth prospect mapping, by product
• Fig. 16 Penetration & growth prospect mapping, by technology
• Fig. 17 Penetration & growth prospect mapping, by application
• Fig. 18 Penetration & growth prospect mapping, by end use
• Fig. 19 Flow cytometry market driver impact
• Fig. 20 Flow cytometry market restraint impact
• Fig. 21 Porter's five force analysis
• Fig. 22 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 23 Flow cytometers import shipments data (2022)
• Fig. 24 Flow cytometers export shipments data (2022)
• Fig. 25 Flow cytometry market: product outlook & key takeaways
• Fig. 26 Flow cytometry market: product movement analysis
• Fig. 27 Global instruments market, 2018 - 2030 (USD Million)
• Fig. 28 Global cell analyzers market, 2018 - 2030 (USD Million)
• Fig. 29 Global cell sorters market, 2018 - 2030 (USD Million)
• Fig. 30 Global reagents & consumables market, 2018 - 2030 (USD Million)
• Fig. 31 Global software market, 2018 - 2030 (USD Million)
• Fig. 32 Global accessories market, 2018 - 2030 (USD Million)
• Fig. 33 Global services market, 2018 - 2030 (USD Million)
• Fig. 34 Flow cytometry market: technology outlook & key takeaways
• Fig. 35 Flow cytometry market: technology movement analysis
• Fig. 36 Global cell-based market, 2018 - 2030 (USD Million)
• Fig. 37 Global bead-based market, 2018 - 2030 (USD Million)
• Fig. 38 Flow cytometry market: application outlook & key takeaways
• Fig. 39 Flow cytometry market: application movement analysis
• Fig. 40 Global research application market, 2018 - 2030 (USD Million)
• Fig. 41 Global pharmaceutical application market, 2018 - 2030 (USD Million)
• Fig. 42 Global drug discovery application market, 2018 - 2030 (USD Million)
• Fig. 43 Global in vitro toxicity application market, 2018 - 2030 (USD Million)
• Fig. 44 Global stem cell application market, 2018 - 2030 (USD Million)
• Fig. 45 Global apoptosis application market, 2018 - 2030 (USD Million)
• Fig. 46 Global cell sorting application market, 2018 - 2030 (USD Million)
• Fig. 47 Global cell cycle analysis application market, 2018 - 2030 (USD Million)
• Fig. 48 Global immunology application market, 2018 - 2030 (USD Million)
• Fig. 49 Global cell viability application market, 2018 - 2030 (USD Million)
• Fig. 50 Global industrial application market, 2018 - 2030 (USD Million)
• Fig. 51 Global clinical application market, 2018 - 2030 (USD Million)
• Fig. 52 Global cancer application market, 2018 - 2030 (USD Million)
• Fig. 53 Global organ transplantation application market, 2018 - 2030 (USD Million)
• Fig. 54 Global immunodeficiency application market, 2018 - 2030 (USD Million)
• Fig. 55 Global hematology application market, 2018 - 2030 (USD Million)
• Fig. 56 Flow cytometry market: end use outlook & key takeaways
• Fig. 57 Flow cytometry market: end use movement analysis
• Fig. 58 Global commercial organizations market, 2018 - 2030 (USD Million)
• Fig. 59 Global biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 60 Global pharmaceutical companies market, 2018 - 2030 (USD Million)
• Fig. 61 Global CROs market, 2018 - 2030 (USD Million)
• Fig. 62 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 63 Global academic institutes market, 2018 - 2030 (USD Million)
• Fig. 64 Global clinical testing labs market, 2018 - 2030 (USD Million)
• Fig. 65 Regional marketplace: key takeaway
• Fig. 66 Flow cytometry market: regional movement analysis
• Fig. 67 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Russia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Heat map analysis, by key market participants
• Fig. 93 Participant categorization - flow cytometry market
• Fig. 94 Public company market position analysis, 2021
• Fig. 95 Global key company market share analysis, 2021
• Fig. 96 Private company market position analysis, 2021
• Fig. 97 Regional network map

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is expected to reach USD 9.28 billion by 2030, registering a CAGR of 7.07% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments.In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications.Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes.The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future.Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

• The instrument product segment held the largest share in 2021 due to technical advancements, as well as increased prevalence of chronic conditions

• Thecell-based flow cytometry technology dominated the industry in 2021 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays

• By application, the clinical segment accounted for the largest revenue share in 2021 owing to increasedR&D activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others

• The academic institutes end-user segment led the market in 2021 owing to increased R&D activities by academic institutes & research centers

• North America was theleadingregion in 2021due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region

• Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Research Methodology
• 1.2 Research Assumptions
  • 1.2.1 Estimates And Forecast Timeline
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.6.2 Volume Price Analysis (Model 2)
    • 1.6.2.1 Approach 2: Volume Price Analysis
• 1.7 List Of Secondary Sources
• 1.8 Objectives
  • 1.8.1 Objective 1:
  • 1.8.2 Objective 2:
  • 1.8.3 Market Estimation For Flow Cytometry Market

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Flow Cytometry Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Related/Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
  • 3.2.1 Key Opportunities Prioritized, By Product
  • 3.2.2 Key Opportunities Prioritized, By Technology
  • 3.2.3 Key Opportunities Prioritized, By Application
  • 3.2.4 Key Opportunities Prioritized, By End Use
• 3.3 Market Dynamics
  • 3.3.1 Market Driver Analysis
    • 3.3.1.1 Growing Prevalence Of Chronic And Infectious Diseases
    • 3.3.1.2 High R&D Investments In Biotechnology, Clinical, And Life Science Research
    • 3.3.1.3 Technological Advancements In Flow Cytometry Instruments And Reagents
    • 3.3.1.4 Increasing Demand For Point-Of-Care Diagnostics
  • 3.3.2 Market Restraint Analysis
    • 3.3.2.1 High Cost Of Instruments
  • 3.3.3 Market Challenges
    • 3.3.3.1 Low Cell Throughput Rate
• 3.4 Flow Cytometry: Market Analysis Tools
  • 3.4.1 Industry Analysis - Porter's
  • 3.4.2 Flow Cytometry - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
• 3.5 Regulatory & Reimbursement Scenario
• 3.6 Pricing Analysis
• 3.7 Trade Data
  • 3.7.1 Import/Export Data For Flow Cytometers, By Country
• 3.8 Covid-19 Impact Analysis

Chapter 4 Product Business Analysis

• 4.1 Flow Cytometry Market: Product Movement Analysis, 2021 & 2030
• 4.2 Instruments
  • 4.2.1 Global Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.2 Cell Analyzers
    • 4.2.2.1 Global Cell Analyzers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.3 Cell Sorters
    • 4.2.3.1 Global Cell Sorters Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.3 Reagents & Consumables
  • 4.3.1 Global Reagents & Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.4 Software
  • 4.4.1 Global Software Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.5 Accessories
  • 4.5.1 Global Accessories Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.6 Services
  • 4.6.1 Global Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Technology Business Analysis

• 5.1 Flow Cytometry Market: Technology Movement Analysis, 2021 & 2030
• 5.2 Cell-Based
  • 5.2.1 Global Cell-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.3 Bead-Based
  • 5.3.1 Global Bead-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

• 6.1 Flow Cytometry Market: Application Movement Analysis, 2021 & 2030
• 6.2 Research
  • 6.2.1 Global Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2 Pharmaceutical
    • 6.2.2.1 Global Pharmaceutical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2.2 Drug Discovery
    • 6.2.2.2.1 Global Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2.3 In Vitro Toxicity
    • 6.2.2.3.1 Global In Vitro Toxicity Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2.4 Stem Cell
    • 6.2.2.4.1 Global Stem Cell Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3 Apoptosis
    • 6.2.3.1 Global Apoptosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4 Cell Sorting
    • 6.2.4.1 Global Cell Sorting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.5 Cell Cycle Analysis
    • 6.2.5.1 Global Cell Cycle Analysis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.6 Immunology
    • 6.2.6.1 Global Immunology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.7 Cell Viability
    • 6.2.7.1 Global Cell Viability Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.3 Industrial
  • 6.3.1 Global Industrial Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4 Clinical
  • 6.4.1 Global Clinical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2 Cancer
    • 6.4.2.1 Global Cancer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3 Organ Transplantation
    • 6.4.3.1 Global Organ Transplantation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4 Immunodeficiency
    • 6.4.4.1 Global Immunodeficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5 Hematology
    • 6.4.5.1 Global Hematology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 End Use Business Analysis

• 7.1 Flow Cytometry Market: End-Use Movement Analysis, 2021 & 2030
• 7.2 Commercial Organizations
  • 7.2.1 Global Commercial Organizations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2 Biotechnology Companies
    • 7.2.2.1 Global Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3 Pharmaceutical Companies
    • 7.2.3.1 Global Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.4 CROS
    • 7.2.4.1 Global CROS Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.3 Hospitals
  • 7.3.1 Global Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.4 Academic Institutes
  • 7.4.1 Global Academic Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5 Clinical Testing Labs
  • 7.5.1 Global Clinical Testing Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Regional Business Analysis

• 8.1 Flow Cytometry Market: Regional Movement Analysis
• 8.2 North America
  • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.2.3 Canada
    • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.3 Europe
  • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3.2 Germany
    • 8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3.3 U.K.
    • 8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3.4 France
    • 8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3.5 Italy
    • 8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3.6 Spain
    • 8.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3.7 Russia
    • 8.3.7.1 Russia Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.3 China
    • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.4 India
    • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.5 South Korea
    • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.6 Australia
    • 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.7 Singapore
    • 8.4.7.1 Singapore Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.3 Mexico
    • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5.4 Argentina
    • 8.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.6 Middle East & Africa
  • 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.4 UAE
    • 8.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Flow Cytometry Market Competitive Landscape

• 9.1 Recent Developments & Impact Analysis, By Key Market Participants
• 9.2 Company Categorization
• 9.3 Vendor Landscape
  • 9.3.1 List Of Key Distributors And Channel Partners
• 9.4 Public Companies
  • 9.4.1 Company Market Position Analysis
  • 9.4.2 Global Key Company Market Share Analysis, 2021
• 9.5 Private Companies
  • 9.5.1 List Of Key Emerging Companies
  • 9.5.2 Company Market Position Analysis
• 9.6 Regional Network Map
• 9.7 Company Profiles
  • 9.7.1 DANAHER CORPORATION
    • 9.7.1.1 Company overview
    • 9.7.1.2 Beckman Coulter, Inc.
    • 9.7.1.2.1 COMPANY OVERVIEW
    • 9.7.1.3 Cytiva
    • 9.7.1.3.1 COMPANY OVERVIEW
    • 9.7.1.4 Financial performance
    • 9.7.1.5 Product benchmarking
    • 9.7.1.6 Strategic initiatives
  • 9.7.2 BECTON, DICKINSON AND COMPANY (BD)
    • 9.7.2.1 Company overview
    • 9.7.2.2 Financial performance
    • 9.7.2.3 Product benchmarking
    • 9.7.2.4 Strategic initiatives
  • 9.7.3 SYSMEX CORPORATION
    • 9.7.3.1 Company overview
    • 9.7.3.2 Financial performance
    • 9.7.3.3 Product benchmarking
    • 9.7.3.4 Strategic initiatives
  • 9.7.4 AGILENT TECHNOLOGIES, INC.
    • 9.7.4.1 Company overview
    • 9.7.4.2 Financial performance
    • 9.7.4.3 Product benchmarking
    • 9.7.4.4 Strategic initiatives
  • 9.7.5 APOGEE FLOW SYSTEMS LTD.
    • 9.7.5.1 Company overview
    • 9.7.5.2 Product benchmarking
    • 9.7.5.3 Strategic initiatives
  • 9.7.6 BIO-RAD LABORATORIES, INC.
    • 9.7.6.1 Company overview
    • 9.7.6.2 Financial performance
    • 9.7.6.3 Product benchmarking
    • 9.7.6.4 Strategic initiatives
  • 9.7.7 THERMO FISHER SCIENTIFIC, INC.
    • 9.7.7.1 Company overview
    • 9.7.7.2 Financial performance
    • 9.7.7.3 Product benchmarking
    • 9.7.7.4 Strategic initiatives
  • 9.7.8 STRATEDIGM, INC.
    • 9.7.8.1 Company overview
    • 9.7.8.2 Product benchmarking
    • 9.7.8.3 Strategic initiatives
  • 9.7.9 DIASORIN S.P.A.
    • 9.7.9.1 Company overview
    • 9.7.9.2 Luminex Corporation
    • 9.7.9.2.1 COMPANY OVERVIEW
    • 9.7.9.3 Financial performance
    • 9.7.9.4 Product benchmarking
    • 9.7.9.5 Strategic initiatives
  • 9.7.10 MILTENYI BIOTEC
    • 9.7.10.1 Company overview
    • 9.7.10.2 Product benchmarking
    • 9.7.10.3 Strategic initiatives
  • 9.7.11 SONY BIOTECHNOLOGY, INC.
    • 9.7.11.1 Company overview
    • 9.7.11.2 Product benchmarking
    • 9.7.11.3 Strategic initiatives